Rexgenero Archives - Interventional News

Rexgenero acquires the key technology and programme assets of aratinga.bio SAS...

22nd June 2020

Rexgenero, a regenerative medicine company developing advanced cell therapies to treat chronic limb-threatening ischaemia (CLTI), has announced the acquisition of all the key assets...

Write to us
Editor: Eva Malpass [email protected]
Advertising: Michael Broughton [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: Rexgenero

Rexgenero acquires the key technology and programme assets of aratinga.bio SAS...